ArticleCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions2026
Outcomes of Different Device Sizing Strategies Using the Newer-Generation WATCHMAN Devices for Closure of Borderline-Sized Left Atrial Appendage.
Article in Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn left atrial appendage closure (LAAC) using newer-generation WATCHMAN FLX/FLX Pro devices, managing borderline-sized LAA within overlapping zones is common, but optimal device sizing strategies remain unknown.
aimsTo compare clinical outcomes and device-related complications between smaller and larger device sizing strategies for borderline-sized LAA.
methodsThis single-center retrospective study evaluated 91 patients undergoing newer-generation WATCHMAN implantation for borderline-sized LAA between September 2021 and June 2024. Follow-up imaging (transesophageal echocardiography and/or cardiac computed tomography angiography) was performed 45-120 days post-LAAC, and one-year clinical outcomes were assessed.
resultsPatients were divided into smaller (n = 36) and larger (n = 55) device groups. The composite primary endpoint (cardiovascular mortality and ischemic stroke) was similar between groups (8.3% vs. 3.6%; hazard ratio [HR], 0.372; 95% CI: 0.074-2.650, p = 0.334). However, the secondary efficacy endpoint-peridevice leak (PDL) 〉3 mm and/or device-related thrombus (DRT)-was significantly higher in the smaller device group at initial follow-up, even after covariate adjustment (13.9% vs. 1.8%; HR, 0.091; 95% CI: 0.009-0.887, p = 0.039). Similar findings were observed at one year.
conclusionFor borderline-sized LAA treated with newer-generation WATCHMAN devices, smaller and larger sizing strategies yielded similar one-year clinical outcomes. However, the larger device strategy showed a lower incidence of PDL >3 mm and/or DRT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.